Heart Disease News and Research

Latest Heart Disease News and Research

Spacelabs receives FDA 510(k) clearance for Blease900 Ventilator

Spacelabs Healthcare today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for the Blease900 Ventilator - an integral component of its BleaseFocus anesthesia system - paving the way for launch of the new BleaseFocus anesthesia system to healthcare facilities in the United States.

9 Jul 2012

Novel treatment for cancer based on protein from HIV-1 virus

Yissum, Research and Development Company of the Hebrew University of Jerusalem, introduces a novel method for treating cancer based on Vif, a protein isolated from the Human Immunodeficiency Virus (HIV-1). The method was invented by Professor Emeritus Moshe Kotler and Dr. Roni Nowarski from the Department of Immunology and Cancer Research at the Hebrew University.

9 Jul 2012

Treatment of Schizophrenia receives notice of intention to grant a European patent

BioLineRx (NASDAQ:BLRX)(TASE:BLRX), a biopharmaceutical development company, announced today that it has received from the European Patent Office a notice of intention to grant a European patent claiming the salt of BL-1020, a first-in-class orally available treatment for schizophrenia.

9 Jul 2012

ImaCor releases Zura EVO ultrasound system

ImaCor Inc., the pioneer of the world's only hemodynamic transesophageal echocardiography (hTEE) management device, today released the Zura EVO ultrasound system.

9 Jul 2012

JRD receives FDA priority review designation for XARELTO sNDAs to treat PE, DVT

Janssen Research & Development, LLC (Janssen R&D) announced today the U.S. Food and Drug Administration (FDA) has assigned a priority review designation to the supplemental New Drug Applications (sNDAs) filed on May 2, 2012 for XARELTO (rivaroxaban), an oral anticoagulant, seeking new indications to treat patients with deep vein thrombosis (DVT), pulmonary embolism (PE), and to prevent recurrent DVT and PE.

9 Jul 2012

FDA approves Capricor’s IND application for myocardial infarction study

Capricor, Inc., a privately held biotechnology company focused on regenerative medicine, today announced that the U.S. Food and Drug Administration has approved initiation of its Investigational New Drug (IND) application for the ALLSTAR study, which will use allogeneic cardiac-derived stem cells (CDCs) to treat patients following large myocardial infarctions (MI).

9 Jul 2012

Next generation predictive 3D cell toxicity assays to be developed by Medicyte GmbH and Reinnervate Ltd

Two market leading companies in the field of cell based assays and predictive toxicology today announced a new product collaboration. Medicyte (inventors of the upcyte® technology) and Reinnervate (market leaders in the growing field of 3D cell culture) said they will work together to combine their upcyte® and Alvetex®Scaffold technologies to bring next generation cell bases assays to the biopharma and academic research markets.

9 Jul 2012

PsiOxus closes Series B round of equity financing

PsiOxus Therapeutics, Ltd. announced that it has closed a Series B round of equity financing totaling £22 million ($34 million).

9 Jul 2012

DNA from CF patients with and without chronic infections points to unsuspected mutation

Comparing the DNA from patients at the best and worst extremes of a health condition can reveal genes for resistance and susceptibly. This approach discovered rare variations in the DCTN4 gene among cystic fibrosis patients most prone to early, chronic airway infections.

9 Jul 2012

Conference highlights utility of zebrafish for human disorder studies

Zebrafish, popular as aquarium fish, now have an important place in research labs as a model organism for studying human diseases.

8 Jul 2012

Extra weight not necessarily linked with higher risk of death

An evaluation of national data by UC Davis researchers has found that extra weight is not necessarily linked with a higher risk of death.

7 Jul 2012

SAGE sponsors symposium on cardiovascular disease prevention

European experts in cardiovascular medicine will today gather at a two day symposium to address the national agenda on cardiovascular disease prevention, held at Imperial College London and sponsored by leading independent academic and professional publisher SAGE.

7 Jul 2012

NIH awards Clinical and Translational Science Award to three Texas Medical Center institutions

In 2006, three Texas Medical Center institutions were among the first in the nation to receive a Clinical and Translational Science Award (CTSA) from the National Institutes of Health (NIH) to accelerate the translation of laboratory discoveries into patient treatments. That grant has been renewed for another 5 years.

7 Jul 2012

State officials pursue divergent paths on health law

Missouri Republicans aim to bar the Democratic governor, or the federal goverment, from setting up an insurance exchange without approval of voters or state legislators, while in Massachusetts, which implemented the prototype of the federal law, 44,000 residents pay fines for not carrying insurance.

7 Jul 2012

Obama assails Romney for shift on mandate

President Barack Obama questions whether Republican Mitt Romney's view that the mandate is a tax is "abandoning a principle" because of pressure from critics. Romney's campaign says he hasn't changed his views, and that the mandate is different on a federal level.

7 Jul 2012

Cystic fibrosis patient receives generous 'gift of life'

Meara Schmidt, 28, almost died a few weeks ago. Lying in her hospital bed at UCLA, the seriously ill cystic fibrosis patient felt herself slipping away and her life flashing by. But then the image of her husband appeared, and she knew she was not ready to go.

7 Jul 2012

NYU Langone completes first year of robotic mitral valve repair program

The Cardiothoracic Surgery Department at NYU Langone Medical Center completed its first year of offering patients endoscopic robotic mitral valve repair surgery. This procedure was introduced at the medical center in the spring of 2011 by Dr. Didier F. Loulmet, a renowned cardiothoracic surgeon who helped develop the procedure.

6 Jul 2012

Novel biomimetic strategy can dissolve blood clots before they cause serious damage or even death

Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University have developed a novel biomimetic strategy that delivers life-saving nanotherapeutics directly to obstructed blood vessels, dissolving blood clots before they cause serious damage or even death.

6 Jul 2012

Employers eye defined contribution health coverage

In other news on health care marketplace issues, TriWest loses its challenge to the Pentagon's new contract for military health care, and researchers find prices increasing for children's care.

6 Jul 2012

New class of injectable materials can stimulate tissue regeneration

The University of Nottingham has begun the search for a new class of injectable materials that will stimulate stem cells to regenerate damaged tissue in degenerative and age related disorders of the bone, muscle and heart.

6 Jul 2012

Heart Disease News and Research

Latest Heart Disease News and Research

Spacelabs receives FDA 510(k) clearance for Blease900 Ventilator

Novel treatment for cancer based on protein from HIV-1 virus

Treatment of Schizophrenia receives notice of intention to grant a European patent

ImaCor releases Zura EVO ultrasound system

JRD receives FDA priority review designation for XARELTO sNDAs to treat PE, DVT

FDA approves Capricor’s IND application for myocardial infarction study

Next generation predictive 3D cell toxicity assays to be developed by Medicyte GmbH and Reinnervate Ltd

PsiOxus closes Series B round of equity financing

DNA from CF patients with and without chronic infections points to unsuspected mutation

Conference highlights utility of zebrafish for human disorder studies

Extra weight not necessarily linked with higher risk of death

SAGE sponsors symposium on cardiovascular disease prevention

NIH awards Clinical and Translational Science Award to three Texas Medical Center institutions

State officials pursue divergent paths on health law

Obama assails Romney for shift on mandate

Cystic fibrosis patient receives generous 'gift of life'

NYU Langone completes first year of robotic mitral valve repair program

Novel biomimetic strategy can dissolve blood clots before they cause serious damage or even death

Employers eye defined contribution health coverage

New class of injectable materials can stimulate tissue regeneration

Industry Focus eBook - Medical device (1st edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Heart Disease News and Research

Latest Heart Disease News and Research

Industry Focus eBook - Medical device (1st edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in